Jpmorgan Chase & CO Amneal Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 519,526 shares of AMRX stock, worth $4.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
519,526
Previous 422,123
23.07%
Holding current value
$4.37 Million
Previous $2.56 Million
28.93%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
182Shares Held
138MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$184 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$118 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.2 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...